These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 32096068)
1. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma. Vallejo FA; Shah SS; de Cordoba N; Walters WM; Prince J; Khatib Z; Komotar RJ; Vanni S; Graham RM J Neurooncol; 2020 Apr; 147(2):317-326. PubMed ID: 32096068 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin. Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886 [TBL] [Abstract][Full Text] [Related]
3. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production. Ji CC; Hu YY; Cheng G; Liang L; Gao B; Ren YP; Liu JT; Cao XL; Zheng MH; Li SZ; Wan F; Han H; Fei Z Int J Oncol; 2020 Feb; 56(2):606-617. PubMed ID: 31894296 [TBL] [Abstract][Full Text] [Related]
4. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca Shin HJ; Lee S; Jung HJ J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways. Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653 [TBL] [Abstract][Full Text] [Related]
7. Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target. Renoult O; Laurent-Blond M; Awada H; Oliver L; Joalland N; Croyal M; Paris F; Gratas C; Pecqueur C Neuro Oncol; 2024 Sep; 26(9):1572-1586. PubMed ID: 38869884 [TBL] [Abstract][Full Text] [Related]
8. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
9. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells. Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970 [TBL] [Abstract][Full Text] [Related]
10. Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells. Daniele S; Pietrobono D; Costa B; Giustiniano M; La Pietra V; Giacomelli C; La Regina G; Silvestri R; Taliani S; Trincavelli ML; Da Settimo F; Novellino E; Martini C; Marinelli L ACS Chem Neurosci; 2018 Jan; 9(1):85-99. PubMed ID: 28368610 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway. Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479 [TBL] [Abstract][Full Text] [Related]
12. Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma. Zhou Y; Li Y; Chenm J; Mei K; Kang M; Chen P; Li Q Hum Gene Ther; 2024 Oct; 35(19-20):838-854. PubMed ID: 39001830 [TBL] [Abstract][Full Text] [Related]
13. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma. Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821 [TBL] [Abstract][Full Text] [Related]
14. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156 [TBL] [Abstract][Full Text] [Related]
15. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. Maurer GD; Brucker DP; Bähr O; Harter PN; Hattingen E; Walenta S; Mueller-Klieser W; Steinbach JP; Rieger J BMC Cancer; 2011 Jul; 11():315. PubMed ID: 21791085 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
17. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
18. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma. Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821 [TBL] [Abstract][Full Text] [Related]
19. Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway. Shukla A; Gupta P; Singh R; Mishra DP Biochem Biophys Res Commun; 2018 May; 499(4):829-835. PubMed ID: 29621542 [TBL] [Abstract][Full Text] [Related]